Domain scores of the nine guidelines assessed by using the AGREE-II instrument (%)
| NICE | MaHTAS | QCG | ISN | AAP | TPA | NPA | INS | SAP | SSN | CPS | ChPS | Mean±SD | |
| Domain 1 | 91.7 | 98.6 | 91.7 | 90.3 | 97.2 | 84.7 | 86.1 | 87.5 | 73.6 | 90.3 | 91.7 | 81.9 | 88.8±6.5 |
| Domain 2 | 93.1 | 61.1 | 66.7 | 61.1 | 51.4 | 44.4 | 50.0 | 56.9 | 18.1 | 36.1 | 22.2 | 9.7 | 47.6±22.4 |
| Domain 3 | 85.9 | 62.5 | 51.0 | 17.2 | 40.6 | 9.9 | 19.8 | 18.2 | 28.1 | 17.2 | 22.4 | 10.4 | 31.9±22.6 |
| Domain 4 | 98.6 | 98.6 | 98.6 | 94.4 | 94.4 | 87.5 | 80.6 | 83.3 | 91.7 | 88.9 | 94.4 | 88.9 | 91.7±5.7 |
| Domain 5 | 85.4 | 64.6 | 61.5 | 26.0 | 38.5 | 25.0 | 57.3 | 37.5 | 24.0 | 39.6 | 29.2 | 27.1 | 43.0±18.9 |
| Domain 6 | 81.3 | 89.6 | 31.3 | 64.6 | 25.0 | 93.8 | 0.0 | 4.2 | 52.1 | 0.0 | 0.0 | 0.0 | 36.8±36.1 |
| Mean±SD | 89.3±5.7 | 79.2±16.7 | 66.8±23.0 | 58.9±29.2 | 57.9±27.9 | 57.6±32.8 | 49.0±30.8 | 47.9±31.1 | 47.9±27.2 | 45.3±33.9 | 43.3±36.3 | 36.3±35.7 |
Domain 1: scope and purpose; domain 2: stakeholder involvement; domain 3: rigour of development; domain 4: clarity of presentation; domain 5: applicability; domain 6: editorial independence.
AAP, American Academy of Pediatrics Subcommittee on Hyperbilirubinemia (America); AGREE, Appraisal of Guidelines for Research & Evaluation; ChPS, Chinese Pediatric Society, Chinese Medical Association (China); CPS, Canadian Pediatric Society, Fetus and Newborn Committee (Canada); INS, Israel Neonatal Society (Israel); ISN, Italian Society of Neonatology (Italy); MaHTAS, Malaysia Health Technology Assessment Section (Malaysia); NICE, National Institute for Health and Care Excellence (the UK); NPA, Norwegian Pediatric Association (Norway); QCG, Queensland Clinical Guidelines (Australia); SAP, Spanish Association of Pediatrics (Spain); SSN, Swiss Society of Neonatology (Swiss); TPA, Turkish Pediatric Association (Turkey).